I see a stock in limbo awaiting Q1 movement towards a clinical trial. Any clinical trial! A clinical trial hasn't been started at Algernon going on 2 years now. All we do is fuckin wait around as the paint dries at Algernon's new HQ location.
I expect the offering will be around $4 per share if they can get it. The same playbook as XORTX.
I also expect the share price will experience what Moreau calls "A Softening" of the share price after the offering
Meaning, 1 $ share price is not out of the realm of possibility. I'm thinking we will see 2 $ again no matter what happens.